Mauro Mastronardi - Publications

Effectiveness and safety of mirikizumab in patients with moderate-to-severe ulcerative colitis: the miri real multicenter study.

Journal: Journal of Crohn's & colitis

Published: June 07, 2026

Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.

Journal: The American journal of gastroenterology

Published: October 27, 2025

Nutritional Management in Stricturing Crohn's Disease: A Pilot Study.

Journal: Nutrients

Published: October 30, 2024

Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease.

Journal: Crohn's & colitis 360

Published: May 30, 2024

Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale.

Journal: Human vaccines & immunotherapeutics

Published: May 16, 2024

Corticosteroid use in patients with inflammatory bowel diseases: A real-life sub-analysis of the Italian DICE study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 27, 2023

Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 30, 2023